Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126673342 | 12667334 | 2 | F | 20160906 | 20160819 | 20160914 | EXP | US-ASTRAZENECA-2016SE85835 | ASTRAZENECA | 0.00 | F | Y | 60.80000 | KG | 20160914 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126673342 | 12667334 | 1 | PS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | 19810 | 40 | MG | CAPSULE | QD | ||||||
| 126673342 | 12667334 | 2 | SS | BRILINTA | TICAGRELOR | 1 | Oral | U | U | 0 | 90 | MG | TABLET | Q12H | |||||
| 126673342 | 12667334 | 3 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0.25MG DAILY AS NEEDED | 0 | TABLET | |||||||||
| 126673342 | 12667334 | 4 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | TABLET | QD | |||||||
| 126673342 | 12667334 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | 0 | 40 | MG | TABLET | QD | ||||||||
| 126673342 | 12667334 | 6 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 MCG/ACTUATION NASAL SPRAY | 0 | ||||||||||
| 126673342 | 12667334 | 7 | C | COZAAR | LOSARTAN POTASSIUM | 1 | Oral | 0 | 50 | MG | TABLET | QD | |||||||
| 126673342 | 12667334 | 8 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | Oral | 0 | 50 | MG | TABLET | BID | |||||||
| 126673342 | 12667334 | 9 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 5-325 MG | 0 | |||||||||||
| 126673342 | 12667334 | 10 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25 MG EVERY SIX HOURS AS NEEDED | 0 | TABLET | |||||||||
| 126673342 | 12667334 | 11 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 50 | MG | CAPSULE | BID | |||||||
| 126673342 | 12667334 | 12 | C | NAPROSYN | NAPROXEN | 1 | 50.0MG UNKNOWN | 0 | 50 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126673342 | 12667334 | 2 | Acute coronary syndrome |
| 126673342 | 12667334 | 3 | Sleep disorder |
| 126673342 | 12667334 | 10 | Nausea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126673342 | 12667334 | HO |
| 126673342 | 12667334 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126673342 | 12667334 | Arteriosclerosis | |
| 126673342 | 12667334 | Cardiomyopathy | |
| 126673342 | 12667334 | Cholelithiasis | |
| 126673342 | 12667334 | Dyslipidaemia | |
| 126673342 | 12667334 | Dysphemia | |
| 126673342 | 12667334 | Gallbladder injury | |
| 126673342 | 12667334 | Hepatic infection | |
| 126673342 | 12667334 | Intentional product misuse | |
| 126673342 | 12667334 | Malaise | |
| 126673342 | 12667334 | Stitch abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |